2m 2m 2m 2m 2m 2m 2m
TRISALS LIFE SCI (TLSI)
NASDAQ
$3.17-$0.17 (-5.10%)
Price as of Jun 03, 2026 7:55 PM EDT- $209.4MMarket Cap
- -35.74%1-Year Change
- Medical DevicesIndustry
TRISALS LIFE SCI (TLSI)
$3.17-$0.17 (-5.10%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 45.2M +53.41% | 29.4M +58.99% | 18.5M N/A | N/A N/A | |
Cost of Revenue | 7.0M +69.75% | 4.1M +57.50% | 2.6M N/A | N/A N/A | |
Gross Profit | 38.2M +50.77% | 25.3M +59.24% | 15.9M N/A | 0 N/A | |
Sales and Marketing Expense | 28.7M +11.11% | 25.8M +51.69% | 17.0M N/A | N/A N/A | |
Research and Development Expense | -15.0M -15.39% | -17.7M -40.06% | -29.5M N/A | N/A N/A | |
Depreciation and Amortization Expense | 626,000 -15.86% | 744,000 +5.98% | 702,000 N/A | N/A N/A | |
Total Operating Expenses | 7.0M +69.75% | 4.1M +57.50% | 2.6M -5.14% | 2.7M -9.69% | |
Operating Profit | -26.9M -25.49% | -36.2M -33.21% | -54.1M +1,871.87% | -2.7M -9.69% | |
Interest Income | 555,000 +37.38% | 404,000 -6.26% | 431,000 -85.72% | 3.0M +4,616.98% | |
Interest Expense | -5.5M +139.13% | -2.3M +14,275.00% | -16,000 N/A | N/A N/A | |
Interest Income and Expense and Net | -4.9M +160.81% | -1.9M -556.87% | 415,000 -86.25% | 3.0M +4,616.98% | |
Total Nonoperating Income and Expense | -456,000 +46.15% | -312,000 -17.68% | -379,000 -104.28% | 8.9M +13.42% | |
Income before Taxes | -39.2M +30.56% | -30.0M -49.11% | -59.0M -1,066.12% | 6.1M +300.94% | |
Income Taxes | 7,000 +16.67% | 6,000 -33.33% | 9,000 -98.42% | 570,854 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -39.2M +30.56% | -30.0M -49.11% | -59.0M -1,165.85% | 5.5M +16.19% | |
Net Income from Continuing Operations Applicable to Common | -69.7M +109.70% | -33.2M -47.48% | -63.3M -1,135.64% | 6.1M +28.16% | |
Basic EPS and Net Income | -1.84 +40.46% | -1.31 -80.53% | -6.73 -1,871.05% | 0.38 +26.67% | |
Diluted EPS and Net Income | -1.84 +40.46% | -1.31 -80.53% | -6.73 -1,871.05% | 0.38 +26.67% | |
Basic Weighted Average Shares | 37.9M +49.61% | 25.3M +169.61% | 9.4M -68.27% | 29.6M -21.04% | |
Diluted Weighted Average Shares | 37.9M +49.61% | 25.3M +169.61% | 9.4M -68.27% | 29.6M -5.25% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 20.4M +139.75% | 8.5M -27.61% | 11.8M +7,569.17% | 153,563 -23.56% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 20.4M +139.75% | 8.5M -27.61% | 11.8M +7,569.17% | 153,563 -23.56% | |
Total Current Assets | 32.2M +56.00% | 20.7M -0.93% | 20.9M +5,696.74% | 359,892 -31.56% | |
Accumulated Depreciation | 3.2M -14.63% | 3.8M +22.44% | 3.1M N/A | N/A N/A | |
Property and Plant and Equipment and Net | 1.8M +8.33% | 1.7M -20.18% | 2.1M N/A | N/A N/A | |
Total Long-Term Assets | 418,000 -1.18% | 423,000 -9.23% | 466,000 -98.37% | 28.6M -88.96% | |
Total Assets | 35.3M +47.39% | 24.0M -6.82% | 25.7M +27.43% | 20.2M -91.94% | |
Income Taxes Payable | 100,000 +194.12% | 34,000 +9.68% | 31,000 +11.29% | 27,854 N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | 944,000 N/A | |
Total Current Liabilities | 11.5M +12.43% | 10.2M -30.36% | 14.7M +487.01% | 2.5M -68.55% | |
Total Long-Term Debt | 33.0M +49.64% | 22.1M N/A | N/A N/A | 200,000 N/A | |
Total Long-Term Liabilities | 45.9M +51.11% | 30.4M +77.78% | 17.1M +74.29% | 9.8M -37.30% | |
Total Liabilities | 69.2M +38.76% | 49.9M -3.48% | 51.7M +278.36% | 13.7M -20.85% | |
Retained Earnings | -330.6M +18.26% | -279.5M +12.55% | -248.4M +1,772.11% | -13.3M -20.64% | |
Total Stockholders Equity | -33.9M +30.77% | -25.9M -0.17% | -25.9M +95.51% | -13.3M -20.64% | |
Total Shares Outstanding | 50.0M +59.84% | 31.3M +18.42% | 26.4M +322.61% | 6.3M 0.00% | |
Cash Flow | |||||
Cash from Operating Activities | -18.0M -55.90% | -40.8M -18.39% | -50.0M +1,728.47% | -2.7M +57.47% | |
Capital Expenditures | 918,000 +166.09% | 345,000 -41.33% | 588,000 N/A | N/A N/A | |
Cash from Investing Activities | -838,000 +142.90% | -345,000 -83.73% | -2.1M -100.91% | 233.2M +388,563.56% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 30.8M -18.91% | 37.9M -30.56% | 54.6M +123.70% | -230.5M -42,472.88% | |
Financials Ratio | |||||
Gross Margin | 84.57% -1.73% | 86.06% +0.15% | 85.93% N/A | N/A N/A | |
Operating Margin | -59.68% -51.43% | -122.88% -57.99% | -292.53% N/A | N/A N/A | |
Return on Assets | -132.30% +9.41% | -120.92% -52.98% | -257.17% -6,384.66% | 4.09% +115.68% | |
Return on Equity | 131.29% +13.25% | 115.93% -61.51% | 301.18% +915.16% | -36.95% +48.03% | |
Revenue Growth | 53.41% -9.46% | 58.99% N/A | N/A N/A | N/A N/A | |
Current Ratio | 2.80 +38.76% | 2.02 +42.27% | 1.42 +887.76% | 0.14 +117.55% | |
Cash Ratio | 1.78 +113.26% | 0.83 +3.94% | 0.80 +1,206.03% | 0.06 +143.65% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | -0.09 N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | 0.06 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow